It is suggested to rotate the location of injection to avoid injection site reactions
What are the Health Benefits
43 Reported adverse reactions in one RTC include headache, facial paresthesia, nausea, biliary colic, vomiting, epigastric pain, and GI disorders, yet they did not differ significantly between placebo and treatment groups
avoid freeze thaw cycles Laboratory research only Not for human or clinical use Handled only by qualified personnel CAS Number: 946870-92-4 Molecular Formula: C400H625N111O115S9 Each batch undergoes internal analytical verification using chromatographic and spectrometric methods prior to lyophilisation
Advanced glycosylation: Chemistry, biology, and implications for diabetes and aging
Cited by: 107 1 Like researcher6076 April 28, 2026, 5:15am #3 FWIW, I do not think FOXO4-DRI has been used in ANY human trials, not Phase 1, not Phase 2, not observational cohorts